This Article Full Text Full Text (PDF) Supplementary Data, Vachani, et al. Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Vachani, A. Articles by Showe, L. C. Search for Related Content PubMed PubMed Citation Articles by Vachani, A. Articles by Showe, L. C.

A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma

Authors' Affiliations: ¹ University of Pennsylvania Medical Center and ² The Wistar Institute, Philadelphia, Pennsylvania; ³ Columbia University Medical Center and ⁴ Memorial Sloan-Kettering Cancer Center, New York, New York; ⁵ University of Minnesota Medical Center, Minneapolis, Minnesota; ⁶ University of North Carolina-Chapel Hill, Chapel Hill, North Carolina; and ⁷ University of Oxford, Oxford, United Kingdom

Requests for reprints: Louise C. Showe, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. E-mail: lshowe{at}wistar.upenn.edu.

Purpose: The risk of developing metastatic squamous cell carcinoma for patients with head and neck squamous cell carcinoma (HNSCC) is very high. Because these patients are often heavy tobacco users, they are also at risk for developing a second primary cancer, with squamous cell carcinoma of the lung (LSCC) being the most common. The distinction between a lung metastasis and a primary LSCC is currently based on certain clinical and histologic criteria, although the accuracy of this approach remains in question.

Experimental Design: Gene expression patterns derived from 28 patients with HNSCC or LSCC from a single center were analyzed using penalized discriminant analysis. Validation was done on previously published data for 134 total subjects from four independent Affymetrix data sets.

Results: We identified a panel of 10 genes (CXCL13, COL6A2, SFTPB, KRT14, TSPYL5, TMP3, KLK10, MMP1, GAS1, and MYH2) that accurately distinguished these two tumor types. This 10-gene classifier was validated on 122 subjects derived from four independent data sets and an average accuracy of 96% was shown. Gene expression values were validated by quantitative reverse transcription-PCR derived on 12 independent samples (seven HNSCC and five LSCC). The 10-gene classifier was also used to determine the site of origin of 12 lung lesions from patients with prior HNSCC.

Conclusions: The results suggest that penalized discriminant analysis using these 10 genes will be highly accurate in determining the origin of squamous cell carcinomas in the lungs of patients with previous head and neck malignancies.